To test the hypotheses that receipt of Medicaid or Medicare versus private insurance or self-pay and low socioeconomic status SES leads to increased mortality and lower chances of transplantation among heart transplant HTx candidates with bridge to transplant left ventricular assist devices BTT LVADs. However, it is unknown whether benefits extend uniformly across patient groups based on insurance status. Multivariable survival analysis was conducted on competing outcomes of mortality and time to transplant stratified by insurance source at the time of listing.
The number of Medicaid beneficiaries has increased under the Affordable Care Act ACAimproving access to solid organ transplantation in this disadvantaged patient cohort. It is unclear what impact Medicaid expansion will have on transplant outcomes. We performed a retrospective cohort analysis to measure the frequency and variation in Medicaid transplantation, and post-transplant survival in Medicaid patients.
Public health insurance programs are covering an increasing number of heart transplant surgeries in the U. In a study published in the Jan. DeFilippis, MD, and colleagues scrutinized de-identified data from the Organ Procurement and Transplantation Network for adult heart transplant recipients between and
The scarcity of human organs requires the transplant community to make difficult allocation decisions. This process begins at individual medical centers, where transplant teams decide which patients to place on the transplant waiting list. Each transplant center utilizes its own listing criteria to determine if a patient is eligible for transplantation.
The number of Medicaid beneficiaries has increased under the Affordable Care Act, improving access to solid organ transplantation in this disadvantaged patient cohort. It is unclear what impact Medicaid expansion will have on transplantation outcomes. We performed a retrospective cohort analysis to measure the frequency and variation in Medicaid transplantation and post-transplantation survival in Medicaid patients.
Heart transplant recipients who accepted donor hearts considered to have an increased risk for disease had a better 1-year survival rate than transplant candidates who refused the higher-risk donor organs, a retrospective analysis of data from the United Network of Organ Sharing UNOS found. Roughly one in five patients who declined the increased-risk donor offers were still waiting for heart transplants 1 year after the initial offer, and 7. The survival rate among patients who accepted the initial increased-risk donor offer was Previous studies have shown survival outcomes to be similar among transplanted patients receiving donor hearts from donors considered to have a normal risk and increased risk for disease.
Despite the rapid growth of ventricular assist devices in heart failure, heart transplantation remains the gold standard for long term outcomes in patients with medically refractory heart failure. The shortcoming in transplantation remains the relatively stable organ supply in the face of rising organ demands. In the United States, the number of heart transplants being performed over the past two decades has remained steady between 2, to 2, being performed annually.